Personal information

Verified email domains

Cell therapy, Dendritic cell vaccines, Immunophenotyping, Biomarkers

Activities

Employment (1)

Mayo Clinic Hospital: Phoenix, Arizona, US

2018-03-26 to present | Scientific Director, Nyberg Human Cellular Therapy Lab (Laboratory Medicine and Pathology)
Employment
Source: Self-asserted source
Michael Gustafson

Education and qualifications (1)

Mayo Clinic: Rochester, Minnesota, US

1995-08 to 2001-05 | PhD (Biochemistry and Molecular Biology)
Qualification
Source: Self-asserted source
Michael Gustafson

Professional activities (6)

International Society for Cellular Therapy: Vancouver, British Columbia, CA

2019-04 to present | Member, Immuno and Gene Therapy
Service
Source: Self-asserted source
Michael Gustafson

American Society for Blood and Marrow Transplantation: Arlington Heights, Illinois, US

2019-03 to present | Member
Membership
Source: Self-asserted source
Michael Gustafson

International Society for Cellular Therapy: Vancouver, British Columbia, CA

2018-05 to present | Member
Membership
Source: Self-asserted source
Michael Gustafson

Society for Immunotherapy of Cancer: Milwaukee, WI, US

2013-05 to present | Champion
Service
Source: Self-asserted source
Michael Gustafson

Society for Immunotherapy of Cancer: Milwaukee, WI, US

2011-01 to present | Member
Membership
Source: Self-asserted source
Michael Gustafson

American Association for Cancer Research: Philadelphia, PA, US

2008-06 to present | Member
Membership
Source: Self-asserted source
Michael Gustafson

Works (50 of 82)

Items per page:
Page 1 of 2

MANUFACTURING OF CLINICAL-GRADE DENDRITIC CELLS FOR TREATMENT OF OVARIAN CANCER

Cytotherapy
2024-06 | Journal article
Contributors: T. Wiltshire; M. Gustafson; M. Deeds; K.L. Knutson; M. Block; A. Dietz
Source: check_circle
Dimensions

MANUFACTURING PROCESS IMPROVEMENT FOR SCALE UP OF AN AUTOLOGOUS ADOPTIVE T CELL PRODUCT

Cytotherapy
2024-06 | Journal article
Contributors: D.S. Missan; G.A. Reckard; L.B. Pathangey; T. Byrd; J. Herring; L. Bergsagel; M. Gustafson
Source: check_circle
Dimensions

VALIDATION OF A FLOW CYTOMETRY RELEASE ASSAY UTILIZING INSTITUTIONAL CLINICAL ASSAY FOR COMPARISON FOR TCRαß+/CD19+ DEPLETED HAPLOIDENTICAL HEMATOPOIETIC PROGENITOR CELL GRAFTS

Cytotherapy
2024-06 | Journal article
Contributors: G.A. Reckard; D.S. Missan; T. Byrd; J. Herring; J. Huey; F.A. Nizzi; J. Adamski; R.H. Adams; M. Otto; M. Gustafson
Source: check_circle
Dimensions

Synthetic Biology Approaches for Enhancing Safety and Specificity of CAR-T Cell Therapies for Solid Cancers

Cytotherapy
2024-03 | Journal article
Contributors: Grace C. Russell; Yassin Hamzaoui; Daniel Rho; Gaurav Sutrave; Joseph S. Choi; Dara S. Missan; Gabrielle A. Reckard; Michael P. Gustafson; Gloria B. Kim
Source: check_circle
Dimensions

Abstract A086: Rapid expansion of natural, MUC1-activated T cells from the peripheral blood of ovarian cancer patients for adoptive cell therapy

Cancer Research
2024-03-04 | Journal article
Contributors: Brenda Ernst; Latha Pathangey; Michael Gustafson; Sandra Gendler; Marion Curtis
Source: check_circle
Dimensions

Unanswered questions following reports of secondary malignancies after CAR-T cell therapy

Nature Medicine
2024-01-09 | Journal article
Contributors: Bruce L. Levine; Marcelo C. Pasquini; John E. Connolly; David L. Porter; Michael P. Gustafson; Jaap J. Boelens; Edwin M. Horwitz; Stephan A. Grupp; Marcela V. Maus; Frederick L. Locke et al.
Source: check_circle
Dimensions

Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer

Frontiers in Immunology
2024-01-03 | Journal article
Contributors: Anupam Kotwal; Michael P. Gustafson; Svetlana Bornschlegl; Allan B. Dietz; Danae Delivanis; Mabel Ryder
Source: check_circle
Dimensions

Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy

Journal of Biological Engineering
2023-07-11 | Journal article
Part of ISSN: 1754-1611
Contributors: Vitali V. Maldonado; Neel H. Patel; Emma E. Smith; C. Lowry Barnes; Michael P. Gustafson; Raj R. Rao; Rebekah M. Samsonraj
Source: Self-asserted source
Michael Gustafson

COVID-19 vaccination produces exercise-responsive SARS-CoV-2-specific T-cells regardless of infection history

Journal of Sport and Health Science
2023-07-01 | Journal article
Contributors: Kyle A Smith; Tiffany M Zúñiga; Forrest L Baker; Helena Batatinha; Charles R Pedlar; Shane C Burgess; Michael P Gustafson; Emmanuel Katsanis; Richard J Simpson
Source: check_circle
Dimensions

Human lymphocytes mobilized with exercise have an anti-tumor transcriptomic profile and exert enhanced graft-versus-leukemia effects in xenogeneic mice

Frontiers in Immunology
2023-04-03 | Journal article
Contributors: Helena Batatinha; Douglass M. Diak; Grace M. Niemiro; Forrest L. Baker; Kyle A. Smith; Tiffany M. Zúñiga; Preteesh L. Mylabathula; Michael D. Seckeler; Branden Lau; Emily C. LaVoy et al.
Source: check_circle
Dimensions

Clonal Kinetics and Single-Cell Transcriptional Profiles of T Cells Mobilized to Blood by Acute Exercise

Medicine & Science in Sports & Exercise
2023-01-26 | Journal article
Contributors: TIFFANY M. ZÚÑIGA; FORREST L. BAKER; KYLE A. SMITH; HELENA BATATINHA; BRANDEN LAU; SHANE C. BURGESS; MICHAEL P. GUSTAFSON; EMMANUEL KATSANIS; RICHARD J. SIMPSON
Source: check_circle
Dimensions

Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experience

Cytotherapy
2022 | Journal article
EID:

2-s2.0-85118702848

Part of ISSN: 14772566 14653249
Contributors: Hanley, P.J.; Bersenev, A.; Gustafson, M.P.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy products

Cytotherapy
2022 | Journal article
EID:

2-s2.0-85119425463

Part of ISSN: 14772566 14653249
Contributors: Bersenev, A.; Gustafson, M.P.; Hanley, P.J.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Emerging frontiers in immuno- and gene therapy for cancer.

Cytotherapy
2022-10-22 | Journal article
Contributors: Gustafson MP; Ligon JA; Bersenev A; Chase D McCann; Shah NN; Patrick J. Hanley
Source: Self-asserted source
Michael Gustafson

Alterations In Inflammatory Markers And Oxidative Stress Following 12 Weeks Of Pulsed Electromagnetic Field Therapy

Medicine & Science in Sports & Exercise
2022-09 | Journal article
Contributors: Dongwook Yeo; Glenn Stewart; Courtney Wheately-Guy; Win-Kuang Shen; Michael Gustafson; Bruce Johnson; Chul-Ho Kim
Source: check_circle
Dimensions

Acute exercise mobilizes NKT-like cells with a cytotoxic transcriptomic profile but does not augment the potency of cytokine-induced killer (CIK) cells.

Frontiers in immunology
2022-09-14 | Journal article
Contributors: Zúñiga TM; Forrest L Baker; Smith KA; Batatinha H; Lau B; Gustafson MP; Katsanis E; Simpson RJ
Source: Self-asserted source
Michael Gustafson

939 Process Development and Manufacturing: VALIDATION OF THE MANUFACTURING OF AUTOLOGOUS MUC-1 ACTIVATED T CELLS FOR A PHASE I DOSE ESCALATION TRIAL FOR PATIENTS WITH MULTIPLE MYELOMA

Cytotherapy
2022-05 | Journal article
Contributors: G.A. McCoy; C.A. Groen; D.S. Missan; L.B. Pathangey; L.W. Myers; J. Adamski; L. Bergsagel; S.J. Gendler; M. Gustafson
Source: check_circle
Dimensions

950 Process Development and Manufacturing: CHARACTERIZING POLYFUNCTIONALITY OF MANUFACTURED T CELL PRODUCTS

Cytotherapy
2022-05 | Journal article
Contributors: D.S. Missan; C.A. Groen; L.W. Myers; L.B. Pathangey; S.J. Gendler; M. Gustafson
Source: check_circle
Dimensions

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma.

Neuro-oncology advances
2022-01-01 | Journal article
Contributors: Ian Parney; S Keith Anderson; Gustafson MP; Steinmetz S; Peterson TE; Kroneman TN; Aditya Raghunathan; O'Neill BP; Jan Buckner; Solseth M et al.
Source: Self-asserted source
Michael Gustafson

Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors

Clinical and Translational Immunology
2021 | Journal article
EID:

2-s2.0-85104973192

Part of ISSN: 20500068
Contributors: Bornschlegl, S.; Gustafson, M.P.; Delivanis, D.A.; Ryder, M.; Liu, M.C.; Vasmatzis, G.; Hallemeier, C.L.; Park, S.S.; Roberts, L.R.; Parney, I.F. et al.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

CD36 Identifies a Subpopulation of Adipose-Derived Mesenchymal Stromal Cells with Enhanced Osteogenic Ability.

Research Square
2021-10-25 | Journal article
Contributors: Emily Camilleri; Scott M. Riester; Michael Gustafson; Catalina Galeano Garces; Christopher R. Paradise; Martina Glusevic; Peggy Bulur; Amel Dudakovic; Allan B. Dietz; Andre J van Wijnen
Source: check_circle
Dimensions

Acute Exercise Enhances The Ex Vivo Expansion And Cytolytic Phenotype Of Cytokine Induced Killer Cells

Medicine & Science in Sports & Exercise
2021-08 | Journal article
Contributors: Tiffany M. Zuniga; Forrest L. Baker; Kyle A. Smith; Michael P. Gustafson; Emmanuel Katsanis; Richard J. Simpson
Source: check_circle
Dimensions

Exercise and the immune system: taking steps to improve responses to cancer immunotherapy

Journal for ImmunoTherapy of Cancer
2021-07 | Journal article
Source: Self-asserted source
Michael Gustafson
grade
Preferred source (of 2)‎

Aggressive Thyroid Cancer is Associated With Suppressor Circulating Immunophenotype

Journal of the Endocrine Society
2021-05-03 | Journal article
Contributors: Anupam Kotwal; Svetlana Bornschlegl; Michael Gustafson; Allan Dietz; Danae Anastasia Delivanis; Mabel M Ryder
Source: check_circle
Dimensions

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Nature Communications
2020 | Journal article
EID:

2-s2.0-85092632289

Part of ISSN: 20411723
Contributors: Block, M.S.; Dietz, A.B.; Gustafson, M.P.; Kalli, K.R.; Erskine, C.L.; Youssef, B.; Vijay, G.V.; Allred, J.B.; Pavelko, K.D.; Strausbauch, M.A. et al.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Novel strategy for manufacturing autologous dendritic cell / allogeneic tumor lysate vaccines for glioblastoma

Neuro-Oncology Advances
2020-08-26 | Journal article
Part of ISSN: 2632-2498
Source: Self-asserted source
Michael Gustafson
grade
Preferred source (of 2)‎

The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction

Neuro-Oncology
2020-07-07 | Journal article
Part of ISSN: 1522-8517
Part of ISSN: 1523-5866
Source: Self-asserted source
Michael Gustafson
grade
Preferred source (of 2)‎

The power of immune profiling: quantitative flow cytometry and informatics approaches to generate pooled biomarkers for therapeutic responsiveness to immune and cellular therapies

Cytotherapy
2020-05 | Journal article
Contributors: S. Bornschlegl; R. Johnson; E. Jacob; N. Staff; M. Gustafson; A. Dietz
Source: check_circle
Dimensions

Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations

Thyroid
2020-05-21 | Journal article
Part of ISSN: 1050-7256
Part of ISSN: 1557-9077
Source: Self-asserted source
Michael Gustafson
grade
Preferred source (of 2)‎

Phenotypic, Transcriptional, and Functional Analysis of Liver Mesenchymal Stromal Cells and Their Immunomodulatory Properties

Liver Transplantation
2020-04 | Journal article
Part of ISSN: 1527-6465
Part of ISSN: 1527-6473
Source: Self-asserted source
Michael Gustafson
grade
Preferred source (of 2)‎

Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine

Clinical Cancer Research
2020-03-01 | Journal article
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Source: Self-asserted source
Michael Gustafson
grade
Preferred source (of 2)‎

The CD14<sup>+</sup>HLA-Dr<sup>lO/NEG</sup> monocyte: An immunosuppressive phenotype that restrains responses to cancer immunotherapy

Frontiers in Immunology
2019 | Journal article
EID:

2-s2.0-85068144628

Contributors: Mengos, A.E.; Gastineau, D.A.; Gustafson, M.P.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

ATIM-29. IDENTIFYING IMMUNOLOGICAL BARRIERS TO IMMUNOTHERAPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME

Neuro-Oncology
2019-11-11 | Journal article
Contributors: Michael Gustafson; Ian Parney; Allan Dietz
Source: check_circle
Dimensions

IMMU-36. THE ROLE OF PD-L1 IN GLIOBLASTOMA-DERIVED EXTRACELLULAR VESICLES IN THE INDUCTION OF IMMUNOSUPPRESSIVE MONOCYTES

Neuro-Oncology
2019-11-11 | Journal article
Contributors: Benjamin Himes; Timothy Peterson; Jasmine Tyson; Helen Lee; Tristan deMooij; Luz Cumba-Garcia; Mi-Yeon Jung; Michael Gustafson; Allan Dietz; Aaron Johnson et al.
Source: check_circle
Dimensions

Conducting maximal and submaximal endurance exercise testing to measure physiological and biological responses to acute exercise in humans

Journal of Visualized Experiments
2018 | Journal article
EID:

2-s2.0-85056287058

Contributors: Wheatley, C.M.; Kannan, T.; Bornschlegl, S.; Kim, C.-H.; Gastineau, D.A.; Dietz, A.B.; Johnson, B.D.; Gustafson, M.P.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year

Kidney International
2018 | Journal article
EID:

2-s2.0-85045181355

Contributors: Taner, T.; Gustafson, M.P.; Hansen, M.J.; Park, W.D.; Bornschlegl, S.; Dietz, A.B.; Stegall, M.D.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Folate receptor alpha peptide vaccine generates immunity in breast and ovarian cancer patients

Clinical Cancer Research
2018 | Journal article
EID:

2-s2.0-85049365468

Contributors: Kalli, K.R.; Block, M.S.; Kasi, P.M.; Erskine, C.L.; Hobday, T.J.; Dietz, A.; Padley, D.; Gustafson, M.P.; Shreeder, B.; Puglisi-Knutson, D. et al.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier
grade
Preferred source (of 2)‎

Sa1480 - Understanding the Immunological Profiles of Somaliamericans with Viral Hepatitis

Gastroenterology
2018-05 | Journal article
Contributors: Essa A. Mohamed; Hamdi A. Ali; Michael Gustafson; Svetlana Bornschlegl; Nasra H. Giama; Hassan M. Shaleh; Ibrahim A. Waaeys; Abdirashid Shire; Allan Dietz; Lewis R. Roberts
Source: check_circle
Dimensions

Tu1261 - Mesenchymal Stem Cells Instigate Creeping Fat Development via Aberrant Immunomodulatory Functions

Gastroenterology
2018-05 | Journal article
Contributors: Mary R. Sagstetter; Peggy A. Bulur; Svetlana Bornschlegl; Olga F. Sarmento; Thomas Smyrk; Michael Gustafson; Phyllis Svingen; Michelle Gonzalez; Adebowale O. Bamidele; Manuel Bonfim Braga Neto et al.
Source: check_circle
Dimensions

A systems biology approach to investigating the influence of exercise and fitness on the composition of leukocytes in peripheral blood

Journal for ImmunoTherapy of Cancer
2017 | Journal article
EID:

2-s2.0-85018477733

Contributors: Gustafson, M.P.; DiCostanzo, A.C.; Wheatley, C.M.; Kim, C.-H.; Bornschlegl, S.; Gastineau, D.A.; Johnson, B.D.; Dietz, A.B.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer

Advances in Radiation Oncology
2017 | Journal article
EID:

2-s2.0-85030025809

Contributors: Gustafson, M.P.; Bornschlegl, S.; Park, S.S.; Gastineau, D.A.; Roberts, L.R.; Dietz, A.B.; Hallemeier, C.L.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Immunosuppressive CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> monocytes are elevated in pancreatic cancer and “primed” by tumor-derived exosomes

OncoImmunology
2017 | Journal article
EID:

2-s2.0-85007318951

Contributors: Javeed, N.; Gustafson, M.P.; Dutta, S.K.; Lin, Y.; Bamlet, W.R.; Oberg, A.L.; Petersen, G.M.; Chari, S.T.; Dietz, A.B.; Mukhopadhyay, D.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier
grade
Preferred source (of 2)‎

Pembrolizumab-induced thyroiditis: Comprehensive clinical review and insights into underlying involved mechanisms

Journal of Clinical Endocrinology and Metabolism
2017 | Journal article
EID:

2-s2.0-85026899671

Contributors: Delivanis, D.A.; Gustafson, M.P.; Bornschlegl, S.; Merten, M.M.; Kottschade, L.; Withers, S.; Dietz, A.B.; Ryder, M.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis

PLOS ONE
2017-07-25 | Journal article
Part of ISSN: 1932-6203
Source: Self-asserted source
Michael Gustafson
grade
Preferred source (of 2)‎

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Cancer Letters
2016 | Journal article
EID:

2-s2.0-84976531382

Contributors: Wang, Y.; Ding, X.; Wang, S.; Moser, C.D.; Shaleh, H.M.; Mohamed, E.A.; Chaiteerakij, R.; Allotey, L.K.; Chen, G.; Miyabe, K. et al.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production

Stem Cell Research and Therapy
2016 | Journal article
EID:

2-s2.0-84992153981

Contributors: Camilleri, E.T.; Gustafson, M.P.; Dudakovic, A.; Riester, S.M.; Garces, C.G.; Paradise, C.R.; Takai, H.; Karperien, M.; Cool, S.; Sampen, H.-J.I. et al.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

IL-10 induces the development of immunosuppressive CD14<sup>+</sup> HLA-DR<sup>low/-</sup> monocytes in B-cell non-Hodgkin lymphoma

Blood Cancer Journal
2015 | Journal article
EID:

2-s2.0-84989336939

Contributors: Xiu, B.; Lin, Y.; Grote, D.M.; Ziesmer, S.C.; Gustafson, M.P.; Maas, M.L.; Zhang, Z.; Dietz, A.B.; Porrata, L.F.; Novak, A.J. et al.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Increased CTLA-4<sup>+</sup> T cells and an increased ratio of monocytes with loss of class II (CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup>) found in aggressive pediatric sarcoma patients

Journal for ImmunoTherapy of Cancer
2015 | Journal article
EID:

2-s2.0-84997766155

Contributors: Hingorani, P.; Maas, M.L.; Gustafson, M.P.; Dickman, P.; Adams, R.H.; Watanabe, M.; Eshun, F.; Williams, J.; Seidel, M.J.; Dietz, A.B.
Source: Self-asserted source
Michael Gustafson via Scopus - Elsevier

Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies

Journal for ImmunoTherapy of Cancer
2015-11-04 | Journal article
Contributors: Michael Gustafson; Yi Lin; Dennis Gastineau; Ian Parney; Allan Dietz
Source: check_circle
Dimensions

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Clinical Cancer Research
2015-09-14 | Journal article
Contributors: Michael P. Gustafson; Yi Lin; Jonathan S. Bleeker; Deepti Warad; Matthew K. Tollefson; Paul L. Crispen; Peggy A. Bulur; Susan M. Harrington; Rebecca R. Laborde; Dennis A. Gastineau et al.
Source: check_circle
Dimensions
Items per page:
Page 1 of 2

Peer review (29 reviews for 3 publications/grants)

Review activity for Cytotherapy. (19)
Review activity for Journal for immunotherapy of cancer. (9)
Review activity for Nature reviews. (1)